DK0737194T3 - Diazabicykliske neurokininantagonister - Google Patents
Diazabicykliske neurokininantagonisterInfo
- Publication number
- DK0737194T3 DK0737194T3 DK94931148T DK94931148T DK0737194T3 DK 0737194 T3 DK0737194 T3 DK 0737194T3 DK 94931148 T DK94931148 T DK 94931148T DK 94931148 T DK94931148 T DK 94931148T DK 0737194 T3 DK0737194 T3 DK 0737194T3
- Authority
- DK
- Denmark
- Prior art keywords
- diazabicyclic
- neurokinin antagonists
- compounds
- formula
- disorders
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17503493A | 1993-12-29 | 1993-12-29 | |
| PCT/IB1994/000352 WO1995018129A1 (en) | 1993-12-29 | 1994-11-14 | Diazabicyclic neurokinin antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0737194T3 true DK0737194T3 (da) | 1999-09-27 |
Family
ID=22638565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94931148T DK0737194T3 (da) | 1993-12-29 | 1994-11-14 | Diazabicykliske neurokininantagonister |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US5854239A (da) |
| EP (1) | EP0737194B1 (da) |
| JP (1) | JP2895630B2 (da) |
| KR (1) | KR100197454B1 (da) |
| CN (1) | CN1046515C (da) |
| AT (1) | ATE177099T1 (da) |
| AU (1) | AU699465B2 (da) |
| BR (1) | BR9408450A (da) |
| CA (1) | CA2180263C (da) |
| CO (1) | CO4230019A1 (da) |
| CZ (1) | CZ282567B6 (da) |
| DE (1) | DE69416869T2 (da) |
| DK (1) | DK0737194T3 (da) |
| ES (1) | ES2127946T3 (da) |
| FI (1) | FI108296B (da) |
| GR (1) | GR3029853T3 (da) |
| HU (1) | HUT74682A (da) |
| IL (1) | IL112118A (da) |
| NO (1) | NO305600B1 (da) |
| NZ (1) | NZ274915A (da) |
| PE (1) | PE49395A1 (da) |
| PL (1) | PL179435B1 (da) |
| RU (1) | RU2124014C1 (da) |
| TW (1) | TW369526B (da) |
| WO (1) | WO1995018129A1 (da) |
| ZA (1) | ZA9410339B (da) |
Families Citing this family (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69416869T2 (de) * | 1993-12-29 | 1999-07-01 | Pfizer | Diazabicyclische neurokinin antagonisten |
| FR2786770B1 (fr) * | 1998-12-04 | 2001-01-19 | Synthelabo | Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique |
| NZ523310A (en) * | 2000-06-12 | 2005-07-29 | Univ Rochester | Tachykinin receptor antagonist to block receptors NK1, NK2, and NK3 and treat symptoms of hormonal variation |
| FR2812635B1 (fr) * | 2000-08-01 | 2002-10-11 | Aventis Pharma Sa | Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens |
| SE0003795D0 (sv) | 2000-10-20 | 2000-10-20 | Astrazeneca Ab | Pharmaceutically useful compounds |
| FR2825705B1 (fr) * | 2001-06-08 | 2005-05-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens |
| FR2835186B1 (fr) * | 2002-01-28 | 2006-10-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases |
| FR2844273B1 (fr) | 2002-09-05 | 2008-04-04 | Aventis Pharma Sa | Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens. |
| US7439253B2 (en) | 2002-12-06 | 2008-10-21 | Novexel | Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors |
| FR2848210B1 (fr) * | 2002-12-06 | 2007-10-19 | Aventis Pharma Sa | Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens et inhibiteurs de beta-lactamases |
| KR101412339B1 (ko) | 2004-07-15 | 2014-06-25 | 알바니 몰레큘라 리써치, 인크. | 아릴- 및 헤테로아릴-치환된 테트라히드로이소퀴놀린, 및이것의 노르에피네프린, 도파민 및 세로토닌의 재흡수를차단하기 위한 용도 |
| US8362075B2 (en) | 2005-05-17 | 2013-01-29 | Merck Sharp & Dohme Corp. | Cyclohexyl sulphones for treatment of cancer |
| WO2006135783A2 (en) * | 2005-06-10 | 2006-12-21 | Wisconsin Alumni Research Foundation | Compositions and methods for modulating angiogenesis |
| US7956050B2 (en) | 2005-07-15 | 2011-06-07 | Albany Molecular Research, Inc. | Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| EP1940842B1 (en) | 2005-09-29 | 2012-05-30 | Merck Sharp & Dohme Corp. | Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
| GB0603041D0 (en) | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
| WO2008039327A2 (en) | 2006-09-22 | 2008-04-03 | Merck & Co., Inc. | Method of treatment using fatty acid synthesis inhibitors |
| US20110218176A1 (en) | 2006-11-01 | 2011-09-08 | Barbara Brooke Jennings-Spring | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
| TWI404532B (zh) * | 2006-11-02 | 2013-08-11 | Targacept Inc | 菸鹼乙醯膽鹼受體亞型選擇性之二氮雜雙環烷類醯胺 |
| PL2336120T3 (pl) | 2007-01-10 | 2014-12-31 | Msd Italia Srl | Kombinacje zawierające indazole podstawione grupą amidową jako inhibitory polimerazy poli(ADP-rybozy) (PARP) |
| US8106086B2 (en) | 2007-04-02 | 2012-01-31 | Msd K.K. | Indoledione derivative |
| CA2690191C (en) | 2007-06-27 | 2015-07-28 | Merck Sharp & Dohme Corp. | 4-carboxybenzylamino derivatives as histone deacetylase inhibitors |
| KR101800610B1 (ko) | 2008-01-18 | 2017-11-23 | 머크 샤프 앤드 돔 코포레이션 | 베타락타마제 억제제 |
| WO2009111354A2 (en) | 2008-03-03 | 2009-09-11 | Tiger Pharmatech | Tyrosine kinase inhibitors |
| US9156812B2 (en) | 2008-06-04 | 2015-10-13 | Bristol-Myers Squibb Company | Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
| WO2010114780A1 (en) | 2009-04-01 | 2010-10-07 | Merck Sharp & Dohme Corp. | Inhibitors of akt activity |
| KR101830447B1 (ko) | 2009-05-12 | 2018-02-20 | 알바니 몰레큘라 리써치, 인크. | 7-(［1,2,4］트리아졸로［1,5-α］피리딘-6-일)-4-(3,4-디클로로페닐)-1,2,3,4-테트라하이드로이소퀴놀린 및 이의 용도 |
| US9034899B2 (en) | 2009-05-12 | 2015-05-19 | Albany Molecular Research, Inc. | Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof |
| WO2010132487A1 (en) | 2009-05-12 | 2010-11-18 | Bristol-Myers Squibb Company | CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROHPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF |
| FR2951171A1 (fr) * | 2009-10-09 | 2011-04-15 | Novexel | Nouveau sel de sodium d'un compose azabicyclique sous forme enantiomere cristallisee et nouvelles formes polymorphes et pseudopolymorphes ainsi que leur preparation |
| PE20121172A1 (es) | 2009-10-14 | 2012-09-05 | Merck Sharp & Dohme | Piperidinas sustituidas con actividad en la hdm2 |
| US8999957B2 (en) | 2010-06-24 | 2015-04-07 | Merck Sharp & Dohme Corp. | Heterocyclic compounds as ERK inhibitors |
| CA2805265A1 (en) | 2010-08-02 | 2012-02-09 | Merck Sharp & Dohme Corp. | Rna interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (ctnnb1) gene expression using short interfering nucleic acid (sina) |
| CA2807307C (en) | 2010-08-17 | 2021-02-09 | Merck Sharp & Dohme Corp. | Rna interference mediated inhibition of hepatitis b virus (hbv) gene expression using short interfering nucleic acid (sina) |
| EP2608669B1 (en) | 2010-08-23 | 2016-06-22 | Merck Sharp & Dohme Corp. | NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS |
| US8946216B2 (en) | 2010-09-01 | 2015-02-03 | Merck Sharp & Dohme Corp. | Indazole derivatives useful as ERK inhibitors |
| US9242981B2 (en) | 2010-09-16 | 2016-01-26 | Merck Sharp & Dohme Corp. | Fused pyrazole derivatives as novel ERK inhibitors |
| EP2632472B1 (en) | 2010-10-29 | 2017-12-13 | Sirna Therapeutics, Inc. | Rna interference mediated inhibition of gene expression using short interfering nucleic acids (sina) |
| US9351965B2 (en) | 2010-12-21 | 2016-05-31 | Merck Sharp & Dohme Corp. | Indazole derivatives useful as ERK inhibitors |
| SG191320A1 (en) * | 2010-12-22 | 2013-07-31 | Meiji Seika Pharma Co Ltd | Optically-active diazabicyclooctane derivative and method for manufacturing same |
| IN2013MN02170A (da) | 2011-04-21 | 2015-06-12 | Piramal Entpr Ltd | |
| PT2748165T (pt) * | 2011-08-27 | 2016-12-28 | Wockhardt Ltd | Derivados de 1,6-diazabiciclo[3,2,1]octano-7-ona e sua utilização no tratamento de infeções bacterianas |
| CA2845108C (en) * | 2011-08-30 | 2015-06-16 | Wockhardt Limited | 1,6-diazabicyclo[3,2,1]octan-7-one derivatives and their use in the treatment of bacterial infections |
| BR112014003476A2 (pt) * | 2011-09-13 | 2017-03-01 | Wockhardt Ltd | compostos contendo nitrogênio e seu uso |
| WO2013063214A1 (en) | 2011-10-27 | 2013-05-02 | Merck Sharp & Dohme Corp. | Novel compounds that are erk inhibitors |
| AR090539A1 (es) * | 2012-04-02 | 2014-11-19 | Astrazeneca Ab | COMPUESTOS INHIBIDORES DE b LACTAMASA |
| EP2844261B1 (en) | 2012-05-02 | 2018-10-17 | Sirna Therapeutics, Inc. | SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS |
| ES2758507T3 (es) * | 2012-05-30 | 2020-05-05 | Meiji Seika Pharma Co Ltd | Nuevo inhibidor de B-lactamasa y método para producir el mismo |
| WO2014052563A2 (en) | 2012-09-28 | 2014-04-03 | Merck Sharp & Dohme Corp. | Novel compounds that are erk inhibitors |
| WO2014078568A1 (en) | 2012-11-14 | 2014-05-22 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
| MX363243B (es) | 2012-11-28 | 2019-03-14 | Merck Sharp & Dohme | Composiciones para tratar cáncer y usos de dichas composiciones. |
| BR112015013611A2 (pt) | 2012-12-20 | 2017-11-14 | Merck Sharp & Dohme | composto, e, composição farmacêutica |
| EP2951180B1 (en) | 2013-01-30 | 2018-05-02 | Merck Sharp & Dohme Corp. | 2,6,7,8 substituted purines as hdm2 inhibitors |
| BR112015021186A2 (pt) * | 2013-03-08 | 2017-07-18 | Wockhardt Ltd | processo para a preparação de (2s,5r)-7-oxo-6-sulfóxi-2-[((3r)-pirrolidina-3-carbonil)-hidrazino carbonil]-1,6-diaza-biciclo[3.2.1]octano |
| BR112015021332B1 (pt) * | 2013-03-08 | 2020-06-30 | Wockhardt Limited | sal de sódio de ácido (2s, 5r)-6-benzilóxi-7-oxo-1,6-diaza-biciclo [3.2.1] octano-2-carboxílico e sua preparação |
| NZ711327A (en) * | 2013-03-08 | 2016-06-24 | Wockhardt Ltd | A process for preparation of (2s, 5r)-7-oxo-6-sulphooxy-2-[((3r)-piperidine-3-carbonyl)-hydrazino carbonyl]-1,6-diaza-bicyclo [3.2.1]- octane |
| JP6182621B2 (ja) * | 2013-03-08 | 2017-08-16 | ウォックハート リミテッド | （２ｓ，５ｒ）−硫酸モノ−｛［（４−アミノピペリジン−４−イル）カルボニル］−７−オキソ−１，６−ジアザ−ビシクロ［３．２．１］オクタ−６−イル｝エステルを調製するための方法 |
| EP3041938A1 (en) | 2013-09-03 | 2016-07-13 | Moderna Therapeutics, Inc. | Circular polynucleotides |
| MY193210A (en) * | 2013-09-24 | 2022-09-26 | Meiji Seika Pharma Co Ltd | Process for producing diazabicyclooctane derivative |
| DK3221313T3 (da) | 2014-11-17 | 2019-04-08 | Entasis Therapeutics Ltd | Kombinationsterapi til behandling af infektioner med resistente bakterier |
| MX2017012545A (es) * | 2015-04-03 | 2018-09-28 | Mutabilis | Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas. |
| LT3512851T (lt) | 2016-09-16 | 2022-10-25 | Entasis Therapeutics Limited | Beta-laktamazės inhibitorių junginiai |
| US11046694B2 (en) | 2017-05-08 | 2021-06-29 | Entasis Therapeutics, Inc. | Compounds and methods for treating bacterial infections |
| WO2019094311A1 (en) | 2017-11-08 | 2019-05-16 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
| CN108610313B (zh) * | 2018-06-08 | 2022-03-04 | 三峡大学 | 一种酶抑制剂及其应用 |
| US20210277009A1 (en) | 2018-08-07 | 2021-09-09 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
| WO2020033284A1 (en) | 2018-08-07 | 2020-02-13 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3494923A (en) * | 1965-05-28 | 1970-02-10 | Sterling Drug Inc | 1,2,3,4,5,8-hexahydro-1,5-methanobenzo (f)(1,4)diazocine |
| DK0573522T3 (da) * | 1991-03-01 | 1995-03-06 | Pfizer | 1-Azabicyclo(3,2,2)nonan-3-aminderivater |
| DE69416869T2 (de) * | 1993-12-29 | 1999-07-01 | Pfizer | Diazabicyclische neurokinin antagonisten |
-
1994
- 1994-11-14 DE DE69416869T patent/DE69416869T2/de not_active Expired - Fee Related
- 1994-11-14 US US08/669,283 patent/US5854239A/en not_active Expired - Fee Related
- 1994-11-14 AU AU80021/94A patent/AU699465B2/en not_active Ceased
- 1994-11-14 BR BR9408450A patent/BR9408450A/pt not_active Application Discontinuation
- 1994-11-14 EP EP94931148A patent/EP0737194B1/en not_active Expired - Lifetime
- 1994-11-14 CA CA002180263A patent/CA2180263C/en not_active Expired - Fee Related
- 1994-11-14 CN CN94194665A patent/CN1046515C/zh not_active Expired - Fee Related
- 1994-11-14 HU HU9601790A patent/HUT74682A/hu unknown
- 1994-11-14 PL PL94315193A patent/PL179435B1/pl unknown
- 1994-11-14 WO PCT/IB1994/000352 patent/WO1995018129A1/en active IP Right Grant
- 1994-11-14 RU RU96116128A patent/RU2124014C1/ru not_active IP Right Cessation
- 1994-11-14 KR KR1019960703516A patent/KR100197454B1/ko not_active IP Right Cessation
- 1994-11-14 ES ES94931148T patent/ES2127946T3/es not_active Expired - Lifetime
- 1994-11-14 CZ CZ961886A patent/CZ282567B6/cs not_active IP Right Cessation
- 1994-11-14 DK DK94931148T patent/DK0737194T3/da active
- 1994-11-14 AT AT94931148T patent/ATE177099T1/de not_active IP Right Cessation
- 1994-11-14 JP JP7508341A patent/JP2895630B2/ja not_active Expired - Fee Related
- 1994-11-14 NZ NZ274915A patent/NZ274915A/en unknown
- 1994-11-28 TW TW083111052A patent/TW369526B/zh active
- 1994-12-21 PE PE1994257627A patent/PE49395A1/es not_active Application Discontinuation
- 1994-12-22 IL IL11211894A patent/IL112118A/en not_active IP Right Cessation
- 1994-12-23 CO CO94058032A patent/CO4230019A1/es unknown
- 1994-12-28 ZA ZA9410339A patent/ZA9410339B/xx unknown
- 1994-12-28 FI FI946140A patent/FI108296B/fi not_active IP Right Cessation
-
1996
- 1996-06-28 NO NO962742A patent/NO305600B1/no unknown
-
1998
- 1998-11-23 US US09/198,171 patent/US6110919A/en not_active Expired - Fee Related
-
1999
- 1999-04-05 GR GR990400941T patent/GR3029853T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0737194T3 (da) | Diazabicykliske neurokininantagonister | |
| FI935585A0 (fi) | Pyrrolopyrimidiner | |
| FI941212A0 (fi) | Fuusioituneet trisykliset, typpeä sisältävät heterosykliset yhdisteet | |
| CA2150123A1 (en) | Aminomethylene substituted non-aromatic heterocycles | |
| ATE166650T1 (de) | Spiroazacyclischderivate als substanz p antagonisten | |
| NO970162D0 (no) | Substituerte pyrimidinforbindelser og anvendelse derav | |
| DK0765320T3 (da) | Benzimidazolonderivater med central dopaminerg aktivitet | |
| SE9702564D0 (sv) | New compounds | |
| MX9700959A (es) | Derivados de becimidazol que tienen actividad dopaminergica. | |
| TR200101476T2 (tr) | N-ikameli azabisikloaklan türevlerinin merkezi sinir sistemi bozukluklarının tedavisinde kullanılması |